Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Deficiency in Untreated CLL
NCT06475469Recruiting
- Sponsor
- CHU de Reims
- Start
- May 2022
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Reims. Primary endpoint: Immunophenotyping of lymphocyte subpopulations. Started May 2022; status: recruiting.
Beyond the preview
Go deeper on NCT06475469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06475469.